Shopping Cart
- Remove All
- Your shopping cart is currently empty
CD70 Trimer Protein, Mouse, Recombinant (His) is expressed in HEK293 Cells. The accession number is O55237.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 μg | $588 | Backorder | |
1 mg | $3,880 | Backorder |
Biological Activity | Immobilized Recombinant Mouse CD70 protein (His Tag) at 2 μg/mL (100 μL/well) can bind Recombinant Mouse CD27 Protein (ECD, mFc Tag), the EC50 is 2.3-6.9 ng/mL. |
Description | CD70 Trimer Protein, Mouse, Recombinant (His) is expressed in HEK293 Cells. The accession number is O55237. |
Species | Mouse |
Expression System | HEK293 Cells |
Tag | N-His |
Accession Number | O55237 |
Synonyms | Tnlg8a,Tnfsf7,Cd70,CD27LG,Cd27l |
Construction | A DNA sequence encoding the Mouse CD70 (NP_035747.1) (Gln47-Pro195) was expressed, with a polyhistidine tag at the N-terminus. |
Protein Purity | ≥ 95% as determined by SDS-PAGE. ≥ 95% as determined by SEC-HPLC. |
Molecular Weight | 51.62 kDa (predicted); 87.6 kDa (reducing contition) |
Endotoxin | < 1.0 EU per μg protein as determined by the LAL method. |
Formulation | Lyophilized from sterile 25mM Sodium Citrate, 200mM NaCl, 10% Trehalose, 10% glycerol, pH 6.0. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
Reconstitution | Please refer to the lot-specific COA. |
Stability & Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping | In general, Lyophilized powders are shipping with blue ice. |
Research Background | CD70, a member of the tumor necrosis factor superfamily, is restricted to activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor, CD27, is important in priming, effector functions, differentiation and memory formation of T-cells as well as plasma and memory B-cell generation. Tight control of CD70 expression is required to prevent lethal immunodeficiency. By selective transcription, CD70 is largely confined to activated lymphocytes and dendritic cells (DC). As a type II transmembrane receptor, CD70 is normally expressed on a subset of B, T and NK cells, where it plays a costimulatory role in immune cell activation. Immunohistochemical analysis of CD70 expression in multiple carcinoma types. The restricted expression pattern of CD70 in normal tissues and its widespread expression in various malignancies makes it an attractive target for antibody-based therapeutics. Investigations to exploit CD70 as a cancer target have lead to the identification of potential antibody-based clinical candidates.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.